Patents by Inventor Hassane Belabed

Hassane Belabed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic compounds as class II phosphoinositide 3-kinase inhibitors
    Patent number: 12247029
    Abstract: Compounds of the following formula: having defined substituents. The compounds can inhibit class II phosphoinositide 3-kinase (PI3K) signaling and are useful for the treatment of a medical condition associated with defective PI3K signaling, such as myopathy, cancer, diabetes, thrombosis or cardiovascular disease.
    Type: Grant
    Filed: June 7, 2019
    Date of Patent: March 11, 2025
    Assignee: Forschungsverbund Berlin e.V.
    Inventors: Wen-Ting Lo, Hassane Belabed, Volker Haucke, Marc Nazare, Murat Kucukdisli
  • HETEROCYCLIC COMPOUNDS AS CLASS II PHOSPHOINOSITIDE 3-KINASE INHIBITORS
    Publication number: 20220332717
    Abstract: Compounds of the following formula: having defined substituents. The compounds can inhibit class II phosphoinositide 3-kinase (PI3K) signaling and are useful for the treatment of a medical condition associated with defective PI3K signaling, such as myopathy, cancer, diabetes, thrombosis or cardiovascular disease.
    Type: Application
    Filed: June 7, 2019
    Publication date: October 20, 2022
    Inventors: Wen-Ting Lo, Hassane Belabed, Volker Haucke, Marc Nazare, Murat Kucukdisli